NEW YORK (GenomeWeb News) - Agilent Technologies said Thursday that fiscal fourth-quarter revenues for its Bio-Analytical Measurement segment rose 24 percent, including revenues from Stratagene, which the company bought in June for around $246 million.
 
The firm’s life sciences sales were particularly strong in the quarter ended Oct. 31, rising 30 percent year over year, or 17 percent excluding Stratagene’s contribution.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Seattle Times writes that pharmacogenomics testing can help choose medications that may work best for people with depression.

Researchers report that deleting one gene from butterflies affects their wing coloration patterns, according to the Washington Post.

In PNAS this week: genome sequencing of weevil symbionts, retinoid X receptor deletion in lung cancer metastasis, and more.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.